{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:54:08Z","timestamp":1782950048658,"version":"3.54.5"},"reference-count":55,"publisher":"Open Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"purpose-of-review\"> <jats:title>Purpose of Review<\/jats:title> <jats:p>Osteoporosis is a common condition affecting the musculoskeletal system. It carries with it increased risks of fracture in many areas of the body, leading to reduced quality of life, limited mobility, and other long-term implications such as chronic pain. Vertebral compression fractures are a common development in patients with osteoporosis. Current treatment options focus on reducing pain; preventative methods are somewhat limited and focus on minimizing risk factors for the development of osteoporosis. In this review, we explore the use of calcitonin (FORTICAL, MIACALCIN) to treat vertebral compression fractures (VCFs).<\/jats:p> <\/jats:sec> <jats:sec id=\"recent-findings\"> <jats:title>Recent Findings<\/jats:title> <jats:p>Osteoporosis had a prevalence of more than 10% in the United States in 2010. The CDC estimates that nearly 25% of women over age 65 have findings of osteoporosis, which include low spinal bone mass. The condition is highly prevalent and, in an aging U.S. population, quite clinically relevant. Risk factors for development include advanced age, cigarette smoking, medications, reduced physical activity, and low calcium and vitamin D intake. Family history may also play a role. Diagnosis is made based on bone mineral density.<\/jats:p> <jats:p>Standard therapy for VCFs in osteoporosis includes analgesic medications, such as NSAIDs and biphosphonates, and surgical intervention. NSAIDs address the chronic pain that is a common long-term effect of VCFs. Biphosphonates have recently been used to attempt to halt the progression and provide prevention. Surgical interventions such as balloon kyphoplasty and vertebroplasty are typically reserved for patients who have failed other methods.<\/jats:p> <jats:p>Calcitonin is a peptide naturally produced by the human body, released from the parathyroid gland. It binds to osteoclasts, inhibiting them from inducing bone resorption. By relatively unknown mechanisms, it also appears to cause endorphin release and mitigate pain. Clinical data has shown safety and efficacy for exogenous calcitonin in reducing bone turnover and reducing VCF-induced pain.<\/jats:p> <\/jats:sec> <jats:sec id=\"summary\"> <jats:title>Summary<\/jats:title> <jats:p>Osteoporosis is a common condition that can lead to complications such as vertebral compression fractures. It can significantly impact the quality of life in many elderly Americans. There is currently no singular treatment, but calcitonin has recently been explored as a possible option for minimizing pain and reducing disease progression. Further studies are needed to understand its preventative benefits fully.<\/jats:p> <\/jats:sec>","DOI":"10.52965\/001c.24976","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T20:06:03Z","timestamp":1625169963000},"source":"Crossref","is-referenced-by-count":10,"title":["Calcitonin (FORTICAL, MIACALCIN) for the treatment of vertebral compression fractures"],"prefix":"10.52965","volume":"13","author":[{"given":"Alicia","family":"Kaneb","sequence":"first","affiliation":[{"name":"Georgetown University School of Medicine, Washington D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Berardino","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine, Washington D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine S.","family":"Hanukaai","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine, Washington D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Rooney","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Science Center, Shreveport, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Louisiana State University Shreveport, LA","department":["Department of Anesthesiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"30777","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"ref1","article-title":"Rockwood and Green\u2019s Fractures in adults. 4th ed, 2 v. Philadelphia: Lippincott-Raven, 1996:1544-5.","author":"J. R. C. Rockwood","year":"1996"},{"issue":"5","key":"ref2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1532-5415.1998.tb01084.x","article-title":"The management of chronic pain in older persons","volume":"46","author":"American Geriatrics Society","year":"1998","journal-title":"Journal of the American Geriatrics Society","ISSN":"https:\/\/id.crossref.org\/issn\/0002-8614","issn-type":"print"},{"issue":"5 SUPPL. 51","key":"ref3","article-title":"Mortality and osteoporotic fractures: Is the link causal, and is it modifiable?","volume":"26","author":"Gim Gee Teng","year":"2008","journal-title":"Clinical and Experimental Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/0392-856X","issn-type":"print"},{"issue":"6","key":"ref4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00198-003-1405-4","article-title":"The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population","volume":"14","author":"M. Naves","year":"2003","journal-title":"Osteoporosis International","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2769-8","article-title":"Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: A meta-analysis of randomized controlled trials","author":"Yuan Zhe Jin","year":"2019","journal-title":"BMC Musculoskeletal Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2474","issn-type":"print"},{"issue":"10","key":"ref6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archinte.162.10.1140","article-title":"Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis","volume":"162","author":"Michael Maricic","year":"2002","journal-title":"Archives of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: The fractureintervention trial","volume":"85","author":"Dennis M. Black","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref8","first-page":"194","article-title":"Prevention of osteoporosis and fractures. 1999;60:194-202.","volume":"60","author":"P Ullom-Minnich","year":"1999","journal-title":"American Family Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-015-3821-5","article-title":"The efficacy of conservative treatment of osteoporotic compression fractures on acute pain relief: a systematic review with meta-analysis","author":"Magdalena Rzewuska","year":"2015","journal-title":"European Spine Journal","ISSN":"https:\/\/id.crossref.org\/issn\/1432-0932","issn-type":"print"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3171\/2016.11.SPINE161031","article-title":"Treatment of thoracolumbar burst fractures: Extended follow-up of a randomized clinical trial comparing orthosis versus no orthosis","volume":"27","author":"Jennifer C. Urquhart","year":"2017","journal-title":"Journal of Neurosurgery: Spine","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5646","issn-type":"print"},{"issue":"August","key":"ref11","first-page":"2005","article-title":"Percentage of Adults Aged 65 and Over With Osteoporosis or Low Bone Mass at the Femur Neck or Lumbar Spine: United States, 2005\u20132010","author":"Anne C. Looker","year":"2015","journal-title":"Centers for Disease Control and Prevention"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jvir.2010.05.018","article-title":"Clinical course of pain in acute osteoporotic vertebral compression fractures","volume":"21","author":"Caroline A.H. Klazen","year":"2010","journal-title":"Journal of Vascular and Interventional Radiology","ISSN":"https:\/\/id.crossref.org\/issn\/1051-0443","issn-type":"print"},{"key":"ref13","article-title":"Balloon kyphoplasty for vertebral compression fractures. Interventional procedures guidance (IPG166)","author":"National Institute for Health and Care Excellence","year":"2006"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/BRS.0000000000000135","article-title":"Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using german claims data","volume":"39","author":"Ansgar Lange","year":"2014","journal-title":"Spine (Phila Pa 1976)","ISSN":"https:\/\/id.crossref.org\/issn\/0362-2436","issn-type":"print"},{"issue":"9","key":"ref15","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1007\/s00586-012-2314-z","article-title":"Comparing effects of kyphoplasty, vertebroplasty, and nonsurgical management in a systematic review of randomized and non-randomized controlled studies","volume":"21","author":"Ioannis D. Papanastassiou","year":"2012","journal-title":"European Spine Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0940-6719","issn-type":"print"},{"key":"ref16","article-title":"Treatment of osteoporotic vertebral compression fractures: Applicability of appropriateness criteria in clinical practice","author":"Rupert Schupfner","year":"2016","journal-title":"Pain Physician","ISSN":"https:\/\/id.crossref.org\/issn\/2150-1149","issn-type":"print"},{"issue":"6","key":"ref17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/neurintsurg-2015-011714","article-title":"Outcomes of vertebroplasty compared with kyphoplasty: A systematic review and meta-analysis","volume":"8","author":"Chris N. Gu","year":"2016","journal-title":"Journal of NeuroInterventional Surgery","ISSN":"https:\/\/id.crossref.org\/issn\/1759-8486","issn-type":"print"},{"issue":"SUPPL.1","key":"ref18","first-page":"41","article-title":"Vertebroplasty and kyphoplasty: A systematic review of 69 clinical studies","volume":"11","author":"P. A. Hulme","year":"2006","journal-title":"European Cells and Materials","ISSN":"https:\/\/id.crossref.org\/issn\/1473-2262","issn-type":"print"},{"key":"ref19","article-title":"Percutaneous vertebroplasty. Interventional procedures guidance (IPG12).","author":"National Institute for Health and Care Excellence","year":"2003"},{"issue":"9746","key":"ref20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(10)60954-3","article-title":"Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): An open-label randomised trial","volume":"376","author":"Caroline A.H. Klazen","year":"2010","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","author":"Nancy E. Lane","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9378","issn-type":"print"},{"issue":"3","key":"ref22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3174\/ajnr.A2817","article-title":"Natural history of pain in patients with conservatively treated osteoporotic vertebral compression fractures: Results from VERTOS II","volume":"33","author":"Alexander Venmans","year":"2012","journal-title":"American Journal of Neuroradiology","ISSN":"https:\/\/id.crossref.org\/issn\/0195-6108","issn-type":"print"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07949-7","article-title":"A brief history of calcitonin","author":"Eric Colman","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00063-6","article-title":"Oral delivery of salmon calcitonin","author":"Yong Hee Lee","year":"2000","journal-title":"Advanced Drug Delivery Reviews","ISSN":"https:\/\/id.crossref.org\/issn\/0169-409X","issn-type":"print"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00688-9","article-title":"Forty years of calcitonin - Where are we now? A tribute to the work of Iain Macintyre, FRS","author":"M. Zaidi","year":"2002","journal-title":"Bone","ISSN":"https:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"issue":"4","key":"ref26","first-page":"600","article-title":"Calcitonin: A useful old friend","volume":"20","author":"Akash Srinivasan","year":"2020","journal-title":"Journal of Musculoskeletal Neuronal Interactions","ISSN":"https:\/\/id.crossref.org\/issn\/1108-7161","issn-type":"print"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200118","article-title":"The analgesic role of calcitonin following osteoporotic fracture","author":"S. L. Silverman","year":"2002","journal-title":"Osteoporosis International","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1744806917720316","article-title":"Mechanisms of the analgesic effect of calcitonin on chronic pain by alteration of receptor or channel expression","volume":"13","author":"Akitoshi Ito","year":"2017","journal-title":"Molecular Pain","ISSN":"https:\/\/id.crossref.org\/issn\/1744-8069","issn-type":"print"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2147\/ijwh.s24776","article-title":"Oral calcitonin","volume":"4","author":"Ronald C. Hamdy","year":"2012","journal-title":"International Journal of Women's Health","ISSN":"https:\/\/id.crossref.org\/issn\/1179-1411","issn-type":"print"},{"issue":"1","key":"ref30","first-page":"111","article-title":"Vertebral Compression Fractures in the Elderly","volume":"69","author":"Jerry L. Old","year":"2004","journal-title":"American Family Physician","ISSN":"https:\/\/id.crossref.org\/issn\/0002-838X","issn-type":"print"},{"issue":"1","key":"ref31","first-page":"111","article-title":"Vertebral Compression Fractures in the Elderly","volume":"69","author":"J. L. Old","year":"2004","journal-title":"Am Fam Physician"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.81.367","article-title":"Involvement of brain serotonergic terminals in the antinociceptive action of peripherally applied calcitonin","author":"Nahoko Yamazaki","year":"1999","journal-title":"Japanese Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0021-5198","issn-type":"print"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0014-2999(85)90284-5","article-title":"The analgesic activity of calcitonin and the central serotonergic system","volume":"108","author":"Giuseppe Clementi","year":"1985","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/0024-3205(79)90433-8","article-title":"Calcitonin and prostaglandin system","volume":"25","author":"A Pecile Ceserani, R, M Colombo, VR Olgiati","year":"1979","journal-title":"Life Sciences"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF01922569","article-title":"Effects of intracerebroventricular calcitonin in the conscious rabbit","volume":"31","author":"V.R. Pecile, A, Ferri, S, Braga, P.C., & Oligiati","year":"1975","journal-title":"Experientia"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00714-7","article-title":"Analgesic effects of calcitonin","author":"G. P. Lyritis","year":"2002","journal-title":"Bone","ISSN":"https:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0091270008329552","article-title":"A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin","volume":"49","author":"Morten A. Karsdal","year":"2009","journal-title":"Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0091-2700","issn-type":"print"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)90189-2","article-title":"Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: Comparison with salmon calcitonin and elcatonin","author":"P. M.J. McSheehy","year":"1995","journal-title":"Bone","ISSN":"https:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-8-12","article-title":"Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin","volume":"8","author":"M. A. Karsdal","year":"2008","journal-title":"BMC Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/1472-6904","issn-type":"print"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: The first tablet formulation of a protein in phase III clinical trials","author":"M. A. Karsdal","year":"2011","journal-title":"Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0091-2700","issn-type":"print"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0765-8","article-title":"Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial","author":"Naoto Endo","year":"2017","journal-title":"Journal of Bone and Mineral Metabolism","ISSN":"https:\/\/id.crossref.org\/issn\/1435-5604","issn-type":"print"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1602","article-title":"A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial","author":"Neil Binkley","year":"2012","journal-title":"Journal of Bone and Mineral Research","ISSN":"https:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.07.019","article-title":"A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D","author":"Kim Henriksen","year":"2016","journal-title":"Bone","ISSN":"https:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555844","article-title":"Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study","author":"G. P. Lyritis","year":"1991","journal-title":"Calcified Tissue International","ISSN":"https:\/\/id.crossref.org\/issn\/0171-967X","issn-type":"print"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1676-0","article-title":"Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: A systematic review and meta-analysis","author":"J. A. Knopp-Sihota","year":"2012"},{"issue":"11","key":"ref46","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1210\/jc.2014-2239","article-title":"Calcitonin Nasal Spray and Increased Cancer Risk: A Population-Based Nested Case-Control Study","volume":"99","author":"Li-Min Sun","year":"2014","journal-title":"The Journal of Clinical Endocrinology & Metabolism","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"12","key":"ref47","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1177\/1060028013509233","article-title":"Salmon Calcitonin Use and Associated Cancer Risk","volume":"47","author":"Robert A. Overman","year":"2013","journal-title":"Annals of Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-019-0563-8","article-title":"Risk factors for conservative treatment failure in acute osteoporotic vertebral compression fractures (OVCFs)","author":"Jia Nan Zhang","year":"2019","journal-title":"Archives of Osteoporosis","ISSN":"https:\/\/id.crossref.org\/issn\/1862-3514","issn-type":"print"},{"issue":"12","key":"ref49","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"O. Johnell","year":"2006","journal-title":"Osteoporosis International","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"issue":"24 SUPPL.","key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199712151-00002","article-title":"Epidemiology of spinal osteoporosis","volume":"22","author":"L. Joseph Melton","year":"1997","journal-title":"Spine (Phila Pa 1976)","ISSN":"https:\/\/id.crossref.org\/issn\/0362-2436","issn-type":"print"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7326\/AWED202001070","article-title":"The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study","volume":"128","author":"Michael C. Nevitt","year":"1998","journal-title":"Annals of Internal Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1539-3704","issn-type":"print"},{"issue":"5","key":"ref52","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a115204","article-title":"Epidemiology of vertebral fractures in women","volume":"129","author":"L. Joseph Melton","year":"1989","journal-title":"American Journal of Epidemiology","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9262","issn-type":"print"},{"key":"ref53","article-title":"Fortical (calcitonin-salmon) [package insert]","author":"Upsher-Smith Laboratories","year":"2014","journal-title":"U.S. Food and Drug Administration website."},{"key":"ref54","article-title":"Miacalcin (calcitonin-salmon) [package insert]","author":"Mylan Institutional","year":"2017","journal-title":"U.S. Food and Drug Administration website"},{"key":"ref55","article-title":"Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral com- pression fractures","author":"National Institute for Health and Clinical Excellence","year":"2013"}],"container-title":["Orthopedic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/orthopedicreviews.openmedicalpublishing.org\/article\/24976-calcitonin-fortical-miacalcin-for-the-treatment-of-vertebral-compression-fractures","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T16:46:42Z","timestamp":1750092402000},"score":1,"resource":{"primary":{"URL":"https:\/\/orthopedicreviews.openmedicalpublishing.org\/article\/24976-calcitonin-fortical-miacalcin-for-the-treatment-of-vertebral-compression-fractures"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.52965\/001c.24976","relation":{},"ISSN":["2035-8164"],"issn-type":[{"value":"2035-8164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]}}}